東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Tumors Interrupt IRF8-Mediated Dendr...

Meyer, Melissa A.

Linked to FindBook

Google Book

Amazon

博客來

Tumors Interrupt IRF8-Mediated Dendritic Cell Development to Overcome Immune Surveillance.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Tumors Interrupt IRF8-Mediated Dendritic Cell Development to Overcome Immune Surveillance./
Author:	Meyer, Melissa A.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2018,
Description:	119 p.
Notes:	Source: Dissertations Abstracts International, Volume: 79-09, Section: B.
Contained By:	Dissertations Abstracts International79-09B.
Subject:	Cellular biology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10745010
ISBN:	9780355663044

Tumors Interrupt IRF8-Mediated Dendritic Cell Development to Overcome Immune Surveillance.
Meyer, Melissa A.

Tumors Interrupt IRF8-Mediated Dendritic Cell Development to Overcome Immune Surveillance. - Ann Arbor : ProQuest Dissertations & Theses, 2018 - 119 p.

Source: Dissertations Abstracts International, Volume: 79-09, Section: B.

Thesis (Ph.D.)--Washington University in St. Louis, 2018.

This item is not available from ProQuest Dissertations & Theses.

Tumors employ multiple mechanisms to evade immune surveillance. One mechanism is tumor-induced myelopoiesis, which expands immune suppressive granulocytes and monocytes to create a protective tumor niche shielding even antigenic tumors. As myeloid cells and immune-stimulatory conventional dendritic cells (cDCs) are derived from the same progenitors, it is logical that tumor-induced myelopoiesis might also impact cDC development. The cDC subset cDC1 is marked by CD141 in humans and CD103 or CD8α in mice. cDC1s act by cross presenting antigen and activating CD8+ T cells. Given these functions, CD103+ cDC1s can support anti-tumor CD8+ T cell responses. However, CD103+ cDC1 numbers are limited within the tumor microenvironment. To understand how CD103+ cDC1s are restricted in the tumor, we investigated their development in the bone marrow (BM). We found that the presence of localized primary tumors resulted in systemic decreases in CD141+ cDC1s in breast and pancreatic cancer patients and animal models. Mechanistically, tumor cell-produced granulocyte stimulating factor (GCSF) mediates the downregulation of the transcription factor interferon regulatory factor 8 (IRF8) in BM progenitors, leading to reduced cellular potential for cDC1 development. Tumor-induced reductions in cDC1-development suppressed the ability of the host to mount anti-tumor CD8+ T cell responses and control tumor growth. Further, BM and systemic decreases in CD141+ cDC1s and their progenitors correlate with patient outcome. Neutralizing GCSF restored cDC1 differentiation and recovered responsiveness to cDC-mediated immunotherapy. These data suggest a new mechanism of immune-escape whereby tumors downregulate cDC1 differentiation from BM progenitors to impair anti-tumor immunity.

ISBN: 9780355663044Subjects--Topical Terms:

3172791
Cellular biology.

Tumors Interrupt IRF8-Mediated Dendritic Cell Development to Overcome Immune Surveillance.
LDR:02972nmm a2200349 4500 001 2207189
005 20190916101758.5
008 201008s2018 ||||||||||||||||| ||eng d
020 $a 9780355663044
035 $a (MiAaPQ)AAI10745010
035 $a (MiAaPQ)wustl:12421
035 $a AAI10745010
040 $a MiAaPQ $c MiAaPQ
100 1 $a Meyer, Melissa A. $3 3434138
245 1 0 $a Tumors Interrupt IRF8-Mediated Dendritic Cell Development to Overcome Immune Surveillance.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2018
300 $a 119 p.
500 $a Source: Dissertations Abstracts International, Volume: 79-09, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: DeNardo, David G.
502 $a Thesis (Ph.D.)--Washington University in St. Louis, 2018.
506 $a This item is not available from ProQuest Dissertations & Theses.
506 $a This item must not be sold to any third party vendors.
520 $a Tumors employ multiple mechanisms to evade immune surveillance. One mechanism is tumor-induced myelopoiesis, which expands immune suppressive granulocytes and monocytes to create a protective tumor niche shielding even antigenic tumors. As myeloid cells and immune-stimulatory conventional dendritic cells (cDCs) are derived from the same progenitors, it is logical that tumor-induced myelopoiesis might also impact cDC development. The cDC subset cDC1 is marked by CD141 in humans and CD103 or CD8α in mice. cDC1s act by cross presenting antigen and activating CD8+ T cells. Given these functions, CD103+ cDC1s can support anti-tumor CD8+ T cell responses. However, CD103+ cDC1 numbers are limited within the tumor microenvironment. To understand how CD103+ cDC1s are restricted in the tumor, we investigated their development in the bone marrow (BM). We found that the presence of localized primary tumors resulted in systemic decreases in CD141+ cDC1s in breast and pancreatic cancer patients and animal models. Mechanistically, tumor cell-produced granulocyte stimulating factor (GCSF) mediates the downregulation of the transcription factor interferon regulatory factor 8 (IRF8) in BM progenitors, leading to reduced cellular potential for cDC1 development. Tumor-induced reductions in cDC1-development suppressed the ability of the host to mount anti-tumor CD8+ T cell responses and control tumor growth. Further, BM and systemic decreases in CD141+ cDC1s and their progenitors correlate with patient outcome. Neutralizing GCSF restored cDC1 differentiation and recovered responsiveness to cDC-mediated immunotherapy. These data suggest a new mechanism of immune-escape whereby tumors downregulate cDC1 differentiation from BM progenitors to impair anti-tumor immunity.
590 $a School code: 0252.
650 4 $a Cellular biology. $3 3172791
650 4 $a Immunology. $3 611031
650 4 $a Oncology. $3 751006
690 $a 0379
690 $a 0982
690 $a 0992
710 2 $a Washington University in St. Louis. $b Biology & Biomedical Sciences (Molecular Cell Biology). $3 1682738
773 0 $t Dissertations Abstracts International $g 79-09B.
790 $a 0252
791 $a Ph.D.
792 $a 2018
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10745010